Gene · 4620
Papers1,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploratory transcriptomic analysis of low-grade oral epithelial dysplasia and oral squamous cell carcinoma in Chilean patients. | Mol Biol Rep | 2026 | 42525276 | PubTator, text mining | PubMed |
| A Novel Homozygous MYH2 Variant Causing Early-Onset External Ophthalmoplegia and Proximal Myopathy in a Consanguineous Family. | Cureus | 2026 | 42491855 | PubTator, text mining | PubMed |
| Systematic reanalysis of next-generation sequencing data in 101 neuromuscular disorder families enhances diagnostic yield, reveals intronic variants, and identifies a novel disease gene. | J Neurol | 2026 | 42474733 | PubTator, text mining | PubMed |
| Substrate stiffness regulates HIF-1α signalling via β1-integrin/myosin-2/NF-κB axis. | J Transl Med | 2026 | 42421092 | PubTator, text mining | PubMed |
| MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy. | J Mol Neurosci | 2026 | 42390820 | PubTator, text mining | PubMed |
| The other half of the sprinting coin: the neuromuscular profile of a 91-yr-old female world record sprinter. | J Appl Physiol (1985) | 2026 | 42090218 | PubTator, text mining | PubMed |
| Whole-exome sequencing unveils novel potential gene mutations involved in primary renal small cell carcinoma. | Oncol Lett | 2026 | 41969585 | PubTator, text mining | PubMed |
| The Conjugated Bile Acids Profile Suggests a Novel Liver-Muscle Axis Associated With Sarcopenia in Chronic Liver Disease. | Liver Int | 2026 | 41902587 | PubTator, text mining | PubMed |
| A new MYH2 variant in an Italian patient expanding the clinical spectrum of MYH2-related myopathy. | BMC Neurol | 2026 | 41851877 | PubTator, text mining | PubMed |
| Quercetin attenuates deoxynivalenol-induced muscle developmental disorders in broilers by modulating the PI3K/Akt/mTOR pathway and reducing apoptosis. | Poult Sci | 2026 | 41850073 | PubTator, text mining | PubMed |
| 0.33g mitigates muscle atrophy while 0.67g preserves muscle function and myofiber type composition in mice during spaceflight. | Sci Adv | 2026 | 41824581 | PubTator, text mining | PubMed |
| MYH9 Variant p.(Arg424Gly) Alters Nonmuscle Myosin IIA Contraction, Causing Atypical MYH9-related Disease. | Kidney Int Rep | 2026 | 41799362 | PubTator, text mining | PubMed |
| MYH9 mutations differentially stabilize non-muscle myosin II filaments and induce distinct cellular aggregation phenotypes. | Cell Mol Life Sci | 2026 | 41760963 | PubTator, text mining | PubMed |
| Ceramide metabolism in oxidative and glycolytic muscle: Significance for lipid-induced insulin resistance. | Mol Metab | 2026 | 41707846 | PubTator, text mining | PubMed |
| Fibre Type-Specific Proteomics Reveals Shared and Distinct Skeletal Muscle Adaptations to Resistance Training and Beta2-Adrenergic Agonist. | J Cachexia Sarcopenia Muscle | 2026 | 41582615 | PubTator, text mining | PubMed |
| Opposing effects of Gα12 and Gα13 loss on myotube size regulation via mTORC1 signaling. | Biochem Biophys Res Commun | 2026 | 41579730 | PubTator, text mining | PubMed |
| Embryotoxicity and mixture effects of legacy PFAS in a human iPSC-based 3D model. | Cell Biol Toxicol | 2026 | 41554909 | PubTator, text mining | PubMed |
| Development of a split-toxin CRISPR screening platform to systematically identify regulators of human myoblast fusion. | Nat Commun | 2026 | 41540035 | PubTator, text mining | PubMed |
| CHAMP1 is an essential regulator for human myoblast fusion and muscle development. | Nat Commun | 2026 | 41540007 | PubTator, text mining | PubMed |
| TGFβ/Smad2/3-Mediated Crosstalk Between Vocal Fold Fibroblasts and Myoblasts In Vitro. | Laryngoscope | 2026 | 41532567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4620/papers